Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcadia Biosciences (RKDA) Return on Sales (2016 - 2025)

Arcadia Biosciences filings provide 12 years of Return on Sales readings, the most recent being 0.0% for Q3 2025.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.0% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.0%, a 2.0% increase, with the full-year FY2024 number at 0.01%, up 1.0% from a year prior.
  • Return on Sales hit 0.0% in Q3 2025 for Arcadia Biosciences, up from 0.0% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.01% in Q4 2021 to a low of 0.09% in Q4 2023.
  • Median Return on Sales over the past 5 years was 0.0% (2024), compared with a mean of 0.01%.
  • The widest YoY moves for Return on Sales: up 24bps in 2021, down -14bps in 2021.
  • Arcadia Biosciences' Return on Sales stood at 0.01% in 2021, then plummeted by -85bps to 0.0% in 2022, then tumbled by -4821bps to 0.09% in 2023, then soared by 100bps to 0.0% in 2024, then soared by 76bps to 0.0% in 2025.
  • The last three reported values for Return on Sales were 0.0% (Q3 2025), 0.0% (Q2 2025), and 0.0% (Q1 2025) per Business Quant data.